GlassScriptPhysician profile
Lauren Davis
NPI 1114521366
$4,001.49
in general payments reported to CMS, 2019-2025
25 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $363 · 2022: $710 · 2023: $937 · 2024: $910 · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,675 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,674.56 |
| Education | $253.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,091.71 | 2021-2025 | Tremfya |
| Lilly USA, LLC | $426.55 | 2021-2025 | Taltz, Ebglyss |
| Novartis Pharmaceuticals Corporation | $403.41 | 2021-2025 | |
| Genzyme Corporation | $330.25 | 2021-2025 | |
| Leo Pharma INC. | $305.14 | 2022-2024 | Adbry |
| Abbvie INC. | $292.38 | 2021-2025 | |
| Ucb, INC. | $277.31 | 2023-2025 | Bimzelx, Cimzia |
| Amgen INC. | $230.79 | 2021-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $167.08 | 2023-2025 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $118.88 | 2022-2023 | Winlevi |
| Sanofi-Aventis U.S. LLC | $64.95 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.54 | 2023 | Spevigo |
| Dermavant Sciences, INC. | $34.98 | 2023-2024 | Vtama |
| Biofrontera INC. | $33.42 | 2023-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Galderma Laboratories, L.P. | $29.44 | 2022-2025 | Nemluvio |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $27.49 | 2023 | Opzelura |
| Biowound Solutions, INC. | $23.24 | 2025 | Bio-Connekt |
| Kyowa Kirin, INC. | $17.50 | 2023 | Crysvita |
| Bioventus LLC | $16.07 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.86 | 2022 | |
| Epi Health, LLC | $14.67 | 2021 | |
| Almirall LLC | $14.15 | 2021 | |
| Integra Lifesciences Corporation | $13.86 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Regeneron Healthcare Solutions, INC. | $11.89 | 2021 | |
| Organon LLC | $5.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.